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ABSTRACT  
The dynamics of L-lactate transport across the blood-brain barrier (BBB) and its cerebral 
metabolism are still subject to debate. We studied lactate uptake and intracellular metabolism 
in the mouse brain using hyperpolarized 13C magnetic resonance spectroscopy (MRS). 
Following the intravenous injection of hyperpolarized [1-13C]lactate, we observed that the 
distribution of 13C label between lactate and pyruvate, which has been shown to be 
representative of their pool size ratio, is different in NMRI and C57BL/6 mice, the latter 
exhibiting a higher cerebral lactate dehydrogenase A (Ldha) expression. Based on this 
observation, and on an additional set of experiments showing that the cerebral conversion of 
[1-13C]lactate to [1-13C]pyruvate increases after exposing the brain to ultrasound irradiation 
that reversibly opens the BBB, it was concluded that lactate transport is rate-limited by the 
BBB, with a 30% increase in lactate uptake after its disruption. It was also deduced from these 
results that hyperpolarized 13C MRS can be used to detect a variation in cerebral lactate 
uptake of less than 40 nmol in a healthy brain during an in vivo experiment lasting only 75 s, 
opening new opportunities to study the role of lactate in brain metabolism. 
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INTRODUCTION 
The role of lactate as a source of energy for the mammalian brain has repeatedly been a 
subject of debate(1-3), but it is established that lactate utilization by the brain increases upon 
elevation of lactate plasma concentration following lactate injection or exercise. While glucose 
is thought to be preferentially taken up by astrocytes(4), a large number of observations show 
that lactate is predominantly taken up by neurons and transformed, via lactate dehydrogenase 
(LDH), into pyruvate for mitochondrial oxidation (5). In mice, it has been demonstrated that 
lactate is metabolized by the intact brain in an activity-dependent manner(3). 
L-lactate can cross the blood-brain barrier (BBB) relatively easily and is taken up by cells 
in the mammalian brain either via monocarboxylate transporters (MCTs) in the plasma 
membrane or by non-saturable diffusion(6). There is an equilibration between blood and brain 
concentrations(1, 7), and at high plasma lactate levels, the transport is dominated by non-
facilitated mechanisms(8).  Earlier studies in rats(9) and in patients(10) had shown that this 
equilibration is not immediate, leaving unsettled the question of the kinetics of lactate transport 
through the BBB. After its uptake into brain cells, lactate rapidly equilibrates with pyruvate 
through the action of LDH. The conversion is a near-equilibrium reaction governed by the 
relation: [pyruvate]/[lactate]= KLDH[NAD+]/([NADH][H+]), where KLDH is the equilibrium constant 
for lactate dehydrogenase. 
13C magnetic resonance spectroscopy (MRS) has been widely used to investigate the 
kinetics of substrate utilization in cerebral intermediary metabolism, in particular following the 
fate of infused 13C-glucose and 13C-lactate. However, this technique is limited by poor 
sensitivity, which precludes directly probing metabolic transformations taking place within the 
first minute of injection. With the advent of dissolution dynamic nuclear polarization (DNP) (11), 
hyperpolarized (HP) 13C MRS has become a powerful technique for monitoring fast metabolic 
conversions in vivo by enhancing the sensitivity of MRS signals up to 4 orders of magnitude(12). 
It is assumed that the lactate-to-pyruvate ratio derived from hyperpolarized 13C-pyruvate can 
be a suitable marker of LDH activity(13-15). Studies using hyperpolarized 13C-pyruvate have also 
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shown that the limited transport of pyruvate across the BBB can be a significant constraint for 
cerebral metabolic studies based on hyperpolarized 13C MRS(16).  
Several recent studies have shown that hyperpolarized 13C-lactate can also be used to 
investigate the lactate-to-pyruvate conversion in vivo(17-22). Compared to pyruvate, 
hyperpolarized lactate has the advantage that a bolus injection does not greatly alter its 
circulating concentration, since lactate has a substantially higher physiological concentration 
than pyruvate in the blood(23). 
It has previously been demonstrated that the 13C-lactate signal detected in vivo following 
the injection of hyperpolarized 13C-pyruvate mostly originates from the rapid 13C label 
exchange catalyzed by LDH and that the net production of lactate is nearly negligible (24, 25). 
The intensity of the lactate signal is therefore expected to be directly related to the 
endogenous lactate pool size and this property can be used to detect tumorous tissue, which 
is known to have a higher lactate concentration than healthy tissue(26). The same holds true for 
the 13C-pyruvate signal measured following the injection of hyperpolarized 13C-lactate, the 
intracellular pyruvate pool being labeled by exchange catalyzed by LDH(20). With both 
hyperpolarized 13C-substrates, the detected pyruvate-to-lactate 13C signal ratio is 
representative of the local pyruvate-to-lactate concentration ratio since LDH governs the 
equilibrium between these two metabolites. 
The aim of the present study was to evaluate the rate-limiting role of the BBB on 
equilibration between plasma and brain within the first minute following the intravenous 
injection of hyperpolarized [1-13C]lactate. We first established that the kinetics of the observed 
cerebral [1-13C]pyruvate signal can provide a measure of cerebral [1-13C]lactate uptake 
through its rapid intracellular equilibration catalyzed by LDH, by performing hyperpolarized 13C 
MRS experiments in two mouse strains, namely C57BL/6 and NMRI, that exhibit differences in 
Ldha expression. The rate-limiting role of the BBB on lactate transport was then assessed by 
disrupting the BBB with ultrasound and microbubbles, following a protocol described in an 
earlier study(27). 
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RESULTS AND DISCUSSION 
The hyperpolarized 13C magnetic resonance (MR) signals originating from the injected 
substrate, [1-13C]lactate (183 ppm), and its metabolites, [1-13C]alanine (176 ppm) and [1-
13C]pyruvate (171 ppm), were detected in all the experiments (n = 19) (Fig. 1). 
[13C]bicarbonate (161 ppm) was also observed in nearly all the experiments (18 out of 19). The 
additional peak observed around 176.5 ppm corresponds to an impurity overlapping with the 
[1-13C]alanine peak and was confirmed by high-resolution 13C NMR of the purchased solution 
(data not shown). Compared to NMRI mice, the pyruvate-to-lactate ratio was clearly smaller in 
C57BL/6 mice (p<0.05), while the bicarbonate-to-lactate ratio was not significantly different 
between the two strains (Fig. 2). 
The origin of the higher pyruvate-to-lactate signal ratio observed in NMRI mice as 
compared to C57BL/6 mice could possibly be explained by a difference in cerebral MCTs 
between the two strains. The quantitative real-time PCR analyses did however not exhibit any 
significant difference in Mct expression (Fig. 3). Since MCTs activity was not measured, it is 
nevertheless not possible to completely rule out that a difference in cerebral MCTs may have 
had an impact on the observed pyruvate-to-lactate signal ratios. The results of the quantitative 
real-time PCR analyses highlighted that Ldha expression in NMRI mice brain was lower than 
in C57BL/6 mice (p < 0.05), while no significant difference was found in Ldhb expression 
between the two strains (Fig. 3). It was previously proposed that increased Ldha might lead to 
an increased lactate concentration in the brain (28, 29). Although the p-value did not reach 
significance, it was also previously observed in a 1H MRS study that C57BL/6 have a higher 
lactate brain concentration than NMRI(30). 
These observations coupled to the fact that no significant difference in blood lactate 
concentration was found between C57BL/6 (1.1 ± 0.2 mM) and NMRI (1 ± 0.1 mM), led us to 
the conclusion that the variation in pyruvate-to-lactate ratio is most likely not due to a 
difference in transport kinetics but rather a reflection of the endogenous lactate pool size. Our 
observation therefore seems to be a confirmation that the pyruvate-to-lactate signal ratio is 
correlated to the ratio between the two metabolite pool sizes and it shows that it is possible to 
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determine variations in lactate pool size using hyperpolarized [1-13C]lactate. Since the 
detected pyruvate signal originates from cerebral tissue only and we did not observe any 
difference in lactate blood concentration between the two strains, we could conclude that our 
observation is related to unequal intracellular concentrations. 
To assess the role of the BBB on the kinetics of L-lactate transport into the brain, we 
measured the cerebral pyruvate signal pre- and post-ultrasound irradiation. The analysis is 
based on the assumption that LDH will nearly instantaneously equilibrate the 13C distribution 
between the two pools as soon as lactate has entered the brain. This assumption is 
reasonable given that the transport kinetics across the BBB is at least one order of magnitude 
slower than the apparent rate constant associated with intracellular transport and LDH activity 
in the rodent brain(16, 31). Because the pyruvate-to-lactate ratio determined from our 
measurements was larger in NMRI mice than in C57BL/6 mice, the study was performed on 
the former strain. To assess the effect of ultrasound on the BBB, T1-weighted images of the 
brain were acquired in NMRI mice after administration of either Gd3+ (Fig. S1) or Mn2+ (Fig. S2). 
The striking change in contrast observed in the images, particularly in the lateral ventricles 
which exhibit a hyperintense signal following ultrasound irradiation, confirmed the opening of 
the BBB after the injection of microbubbles and the application of ultrasound. 
To quantify the increase in intracellular cerebral lactate after ultrasound application, we 
propose the following model illustrated in Fig. 3: in the absence of ultrasound (US) exposure, 
the pyruvate-to-lactate 13C signal ratio can be written as follows,  
brain
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where the [1-13C]pyruvate signal (Sbrainpyr) originates exclusively from the brain cells. If we 
assume that the 13C fractional enrichment for both pyruvate and lactate brain pools are equal 
due to the rapid exchange through LDH, 
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where [pyr] and [lac] are the pyruvate and lactate brain concentrations, respectively. When the 
brain is exposed to ultrasound irradiation, brainlacS  can be replaced by ( )δ+⋅ 1brainlacS , withδ the 
portion of 13C signal originating from the increase in brain lactate during the measurement. We 
obtain 
( ) [ ][ ]
1brainlac
pyr
blood brain
lac lac lacUS
pyr
S
S lac
S S S
δ⋅ +
=
+
,        (3) 
where bloodlacS is assumed to be identical in both cases because the reduction of blood lactate 
due to higher cerebral uptake is negligible, and that brainlac
brain
lac
blood
lac SSS ⋅>>+ δ to approximate 
the denominator from ( )δ+⋅+ 1brainlacbloodlac SS  to brainlacbloodlac SS + . Therefore, the change in 13C 
signal ratio induced by the application of ultrasound is reduced to 
( )1pyr pyr
lac lacUS No US
S S
S S
δ= ⋅ + .         (4) 
The pyruvate-to-lactate ratio measured in mice exposed to ultrasound irradiation was 
significantly higher than in mice that did not experience ultrasound exposure (Fig. 5). The 
28±3% increase (p<0.05) post ultrasound demonstrates that the BBB limits the transport of 
lactate into the brain. Although the difference in bicarbonate-to-lactate ratio did not quite reach 
significance (p=0.45), most likely because of low SNR, the observed trend towards increased 
conversion also points in the direction of an increased lactate transport rate post ultrasound. 
It has been shown that the intracellular and extracellular hyperpolarized [1-13C]lactate 
signals can be separated in vitro(32). It was however not possible to achieve the required 
spectral resolution in the present in vivo study. As a consequence, we could not deduce the 
Michaelis-Menten constants associated with BBB transport. However, because of the rapid 
exchange catalyzed by LDH, the detection of cerebral pyruvate provides an indirect readout of 
lactate transport into the brain. In fact, the increase in pyruvate-to-lactate ratio following 
ultrasound irradiation corresponds to a quantitative measurement of the increased cerebral 
lactate uptake, δ (see Equation 4). We conclude that the application of ultrasound led to an 
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increase of 28±3% of cerebral lactate within the 75 s experiment. It was previously 
demonstrated that lactate flux through the BBB via non-facilitated transport is roughly identical 
to the flux via MCTs in the rat brain across a large lactate plasma concentration(33). Assuming 
the uptake via MCTs was not substantially affected by ultrasound, non-facilitated transport 
would then account for the nearly 30% increase of lactate uptake after opening the BBB. Note 
that because the pyruvate and bicarbonate signals originate from the intracellular 
compartment, their intensity will not be affected by a potential variation in extracellular pH that 
may result from the opening of the BBB. 
Using Vmax = 300 nmol⋅g-1⋅min-1 and KM = 13 mM as the Michaelis-Menten constants for 
the kinetics of lactate transport across the BBB(8), we estimate for a 700 mg mouse brain (42 g 
body weight corresponds to 0.017 ⋅ 42 = 0.7 g brain weight for a male(34)), with 13 mM lactate 
in the blood, that approximately 150 ⋅ 0.7 ⋅ 75 / 60 = 130 nmol of lactate entered the brain 
during the 75 s experiment. This is consistent with the results obtained in NMRI mice using 
thermally polarized [3-13C]lactate, where 516 nmol was estimated to be taken up by the brain 
within 5 min of a bolus injection (with a nearly 5 times higher lactate dose than in the present 
study)(35). It can therefore be concluded that the method herein presented allows for the 
detection of a 130 ⋅ 0.28  ≅ 36 nmol increase in lactate uptake upon BBB opening by 
ultrasound, demonstrating the high sensitivity of hyperpolarized 13C MRS for studying cerebral 
metabolism(36). For future hyperpolarized 13C MR imaging studies aiming at correlating the 
spatio-temporal evolution of the BBB opening with hyperpolarized 13C MRI, it would be 
necessary to determine the spatio-temporal delivery of small molecules like 13C-lactate as was 
done by Choi et al. with Gd-based contrast agents(37). 
 The dynamics of substrate transport across the BBB has previously been studied using 
hyperpolarized 13C MR. Hurd et al. looked at the cerebral metabolism of [1-13C]pyruvate(16) and 
ethyl [1-13C]pyruvate(31). Because the flux through MCTs is on the order of 4 times slower for 
pyruvate than for lactate(38), and the pyruvate plasma concentration largely exceeded KM, it 
can be assumed that MCTs were saturated following the injection of hyperpolarized 13C-
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pyruvate. Consequently, the non-saturable flux could be considered as the main contribution 
to transport across the BBB, but the more hydrophobic precursor ethyl [1-13C]pyruvate crossed 
the BBB much faster and resulted greater cerebral [1-13C]lactate production. Although the 
results of this previous study are of high importance in the context of hyperpolarized 13C MR 
because 13C-pyruvate is by far the most widely used substrate and to date the only one used 
in humans, the authors highlighted that the contribution of extracellular 13C lactate to the 
measured brain signal is difficult to estimate. For this reason, injecting hyperpolarized 13C-
lactate is an interesting alternative because the signal from its metabolic product pyruvate is 
purely intracellular. In fact, both pyruvate and lactate concentrations stay near physiological 
range following the injection of a bolus of hyperpolarized 13C-lactate. The disadvantages of 
using hyperpolarized 13C-lactate are that the fractional 13C enrichment of brain lactate during 
the timeframe of the experiment is limited and the pool size of pyruvate is small, leading to 
lower sensitivity as compared to experiments done with hyperpolarized 13C-pyruvate. It is 
however worth noting that the bicarbonate signal intensity is not substantially larger in 
experiments with hyperpolarized 13C-pyruvate with similar 13C polarization level using the 
same equipment (39). It can also be mentioned here that the use of sodium lactate instead of 
lactic acid, which is considerable less stable, highly simplifies sample preparation and 
precludes the need for adding sodium hydroxide to reach physiological pH in the 
hyperpolarized 13C-lactate solution prior to injection. Note finally that alternative 
hyperpolarized 13C MR approaches based on flow(40), chemical shift(32, 41), and diffusion 
weighting measurements(42, 43) could be used to study the impact of ultrasound on transport 
dynamics of small molecules across the BBB. 
 
CONCLUSION 
We demonstrated that L-lactate transport across the BBB can be observed using 
hyperpolarized 13C-lactate and we deduced that its transport is limited by the BBB. Our 
findings show that the equilibration between plasma and brain lactate is not instantaneous and 
that the BBB can restrict diffusion into the brain by nearly 30% at high plasma lactate 
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concentration. We also deduced that, although an exact determination of metabolite 
concentrations is challenging using hyperpolarized 13C, variations of less than 40 nmol in 
cerebral lactate uptake can be detected. Our study shows that [1-13C]lactate is a promising 
molecule for studying cerebral metabolism by hyperpolarized 13C MRS since the injected 
substrate and its metabolites, namely pyruvate and bicarbonate, remain and can be detected 
at near physiological concentration. Hyperpolarized 13C-lactate could also be potentially 
considered as a non-toxic alternative to lanthanide-based contrast agents for diagnosing brain 
tumors through the evaluation of BBB integrity by MRI. 
 
MATERIALS AND METHODS 
All experiments were conducted in accordance with the Animal Research: Reporting of In Vivo 
Experiments (ARRIVE) guidelines and were approved by the local regulatory body of the 
Canton Vaud, Switzerland (Service de la consommation et des affaires vétérinaires, Affaires 
vétérinaires, Canton de Vaud, Suisse). All animals were purchased from Charles River 
Laboratories (Châtillon-sur-Chalaronne, France). 
 
Animal preparation and injection protocol 
A total of 7 C57BL/6J mice (29.1 ± 1.5 g, 10 – 24 weeks, male) and 17 NMRI mice (41.7 
± 1.4 g, 10 - 24 weeks, male) were purchased for the magnetic resonance (MR) experiments. 
All mice were anesthetized using 1.5-2% isoflurane in air containing 50% oxygen (1 L/min). A 
12-cm long home-made catheter was introduced into the femoral vein 60 min before each 
hyperpolarized 13C MRS experiment. Animal physiology, e.g. body temperature and respiration 
rate, were monitored and maintained stable during the experiments by controlling the 
temperature of circulating warm water and the amount of isoflurane delivered to the animal. 
The animals were euthanized in accordance with local guidelines at the end of each 
hyperpolarized 13C MRS experiment. 
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Preparation of hyperpolarized [1-13C]lactate solution  
A mixture of sodium [1-13C]lactate solution (45-55 % (w/w) in H2O, 99 atom % 13C) and 
d8-glycerol (1:1 w/w) doped with 50 mM 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl 
(TEMPOL) radical was warmed for 15 min in a water bath at 50°C(17-22). All chemicals were 
purchased from Sigma-Aldrich (Buchs, Switzerland). A total volume of 0.2 mL of 2 ± 0.5 µL 
frozen beads were prepared in liquid nitrogen and placed into a polytetrafluoroethylene (PTFE) 
sample cup described in a previous publication(44). The cup was then loaded into a 5 T home-
built DNP polarizer and polarized at 1 ± 0.05 K and 140.18 GHz with a millimeter-wave power 
output of 50 mW(45). The solid-state 13C polarization build-up was monitored by applying a 5° 
radiofrequency (rf) pulse every 5 min. 
 
In vivo hyperpolarized 13C MRS  
All in vivo MR acquisitions were performed with a Direct Drive spectrometer (Agilent, 
Palo Alto, CA, USA) interfaced to an actively-shielded 9.4-T magnet with a 31-cm horizontal 
bore (Magnex Scientific, Abingdon, UK) using a home-built dual-channel surface coil 
consisting of 12-mm diameter quadrature 1H loops and an 8-mm diameter 13C surface coil. 
After having positioned the animal inside the magnet, series of axial, sagittal and coronal 2D 
images were acquired using a gradient echo sequence (TR = 50 ms, TE = 3 ms, field of view = 
30 × 30 mm, matrix =128 × 128, flip angle = 30°) from which the volume of interest (VOI) was 
selected. The static magnetic field was shimmed in a 75 µL (3 × 5 × 5 mm3) voxel to reduce 
the localized proton line width to 20 Hz using the FAST(EST)MAP protocol(46).  
After 2 h of polarization, the frozen beads were rapidly dissolved in 6 mL of superheated 
D2O and transferred into the separator/infusion pump(44, 47), which was located inside the 
magnet bore in 2 s. A 13C polarization of 10 ± 2% was measured at the time of injection inside 
the pump as described in a previous publication(47). The concentration of the infusate, 
measured afterwards in a high-resolution NMR system, was 110 ± 20 mM. Either 200 µL (for 7 
C57BL/6 mice) or 300 µL (for 12 NMRI mice) of hyperpolarized [1-13C]lactate solution was 
injected within 5 s, corresponding to a volume-to-weight ratio of about 7 µL/g. The blood 
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concentration at the end of the injection was estimated to be 13±3 mM. Starting 5 s after 
dissolution, 40 single-pulse 13C acquisitions were sequentially recorded every 3 s using 30° 
adiabatic rf pulses (BIR4) with 1H decoupling during acquisition (WALTZ-16). Localization was 
achieved by placing the surface coil on top of the mouse head. The adiabatic pulse offset and 
power were set such as to ensure a homogeneous 30° excitation of substrate and metabolite 
resonances within the entire VOI. 
After inducing the BBB opening in NMRI mice, hyperpolarized [1-13C]lactate was injected 
using the same protocol as the one used without ultrasound application.   
 
Quantitative real-time PCR analysis and blood lactate measurement 
A set of 7 C57BL/6J mice (28.4 ± 0.5 g, 10 weeks, male) and 7 NMRI mice (42.4 ± 1.0 g, 10 
weeks, male) were dedicated to PCR analyses. Quantitative real-time PCR was performed to 
measure the expression levels of Ldha, Ldhb, Slc16a1 (MCT1), Slc16a7 (MCT2), and Slc16a3 
(MCT4) transcripts associated with the metabolism of [1-13C]lactate for both C57BL/6 mice and 
NMRI mice. Plasma lactate was measured with the lactate oxidase method using a multi-
assay analyzer (GW7 Micro-Stat, Analox Instruments, London, UK). For the QPCR measure, 
mice were rapidly killed with a guillotine and brains extracted. 40 mg of brain cortex was 
directly mixed in lysis solution. RNA was extracted using the Maxwell 16 LEV simplyRNA Cells 
kit (Promega, ref AS1270) following manufacturer instructions. Reverse transcriptions were 
performed with the High Capacity RNA-to-cDNA Kit (Life Technologies) according to the 
manufacturer’s instructions. Each reaction was done in 20 µl with 400 ng of mRNA. 
Quantitative determination of the targeted mRNA sequences were performed with the fast real 
time PCR system Applied Biosystem 7900HT (Applied Biosystens, Rotkreuz, Switzerland). 
The following primers (5’ to 3’) were used: mActinBF031 GCT TCT TTG CAG CTC CTT CGT; 
mActinbRE94 ATA TCG TCA TCC ATG GCG AAC; mLDHAFo427 TTG TCT CCA GCA AAG 
ACT ACT GTG T; mLDHARe536 TTT CGC TGG ACC AGG TTG AG; mLDHBFo312 GCA 
GCA CGG GAG CTT GTT; mLDHBRe389 CAA TCT TAG AGT TGG CTG TCA CAG A; 
mMCT1Fo1361 AAT GCT GCC CTG TCC TCC TA; mMCT1Re1441 CCC AGT ACG TGT 
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ATT TGT AGT CTC CAT; mMCT2Fo755 CAG CAA CAG CGT GAT AGA GCT T; 
mMCT2Re830 TGG TTG CAG GTT GAA TGC TAA T; mMCT4Fo320 TCT GCA GAA GCA 
TTA TCC AGA TCT A; mMCT4Re407 ATG ATG AGG GAA GGC TGG AA. Gene expression 
data were analyzed using an Excel macro from Frontiers in Genetics (RT-PCR analysis-macro 
version 1.1). The average quantities were normalized to a normalization factor obtained by 
calculating the geometric mean of the most stable reference gene(48). For the normalization 
factor, we tested the β-actin, cyclophilin, hypoxanthine guanine phosphoribosyl transferase 
and TATA box binding protein genes and chose β-actin as it was the most stable gene in our 
study. 
 
Protocol for BBB opening 
The BBB was opened using a previously described method(49). In brief, a circular single-
element ultrasound transducer (model A306S-SU, Olympus NDT) with a diameter of 13 mm 
and a center frequency of 2.25 MHz was used in this study. Using a stereotaxic instrument, 
the transducer was positioned at its natural focal distance (58 mm) in a column of degassed 
water (contained by a thin plastic film) placed directly over the mouse brain. The transducer 
was driven by a 47 dB power amplifier (model RF0510-200; RFPA, France), which was fed by 
a periodic pulse sequence from a signal generator (model 33220A, Agilent, Santa Clara, CA). 
The pulse sequence consisted of bursts of 2.15 MHz sinusoidal pulses with 50,000 cycles per 
burst and a burst period of 64 ms. The pulse amplitude was calibrated to generate negative 
acoustic pressure peaks of 0.5 MPa at the center of the natural focus of transducer. Power 
output of the ultrasonic transducer was calibrated in a water bath using a needle hydrophone 
(1-mm diameter needle hydrophone probe containing a 28-µm thick gold electroded 
polyvinylidene fluoride film, Precision Acoustics Ltd, UK). 
Prior to the application of ultrasonic excitation, hair was removed from the mouse scalp 
using an electric trimmer. Ultrasound gel was placed on the scalp and the water column was 
lowered onto the head. A 100µL bolus of sulfur hexafluoride microbubbles with phospholipid 
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shell (SonoVue, Bracco Imaging, Milan, Italy) was administered through the femoral vein 
within 5 s, about 1 min before ultrasound irradiation. Following microbubble injection, the 
ultrasound pulse sequence was initiated and maintained for 10 min. Note that to insure an 
effective opening of the BBB, we applied a substantially longer pulse (10 min instead of 3 min) 
than in the original protocol published by Howles et al.(49). We did however not specifically 
quantify skull attenuation in this study but it was previously demonstrated that the opening of 
the BBB in mice can be induced with ultrasound without craniotomy by compensating for the 
about 20% attenuation in pressure amplitude(50). 
The efficacy of the protocol to open the BBB was evaluated via T1-weighted MRI scans 
using either a gadolinium-based contrast agent, Gadoteridol (ProHance, Bracco Imaging, 
Milan, Italy), injected intraperitoneally 20 min before imaging at a concentration of 2 mmol/kg, 
or a 100 mM MnCl2 solution (Sigma-Aldrich, Buchs, Switzerland) injected intraperitoneally 30 
min before imaging at a concentration of 0.4 mmol/kg(51). We used a three-dimensional spoiled 
gradient-recalled (SPGR) MRI sequence with the following parameters (49): pulse repetition (TR) 
= 25 ms; echo time = 6 ms; flip angle = 30°; field of view = 20 × 20 × 16; matrix = 256 × 256 × 
32; number of averages = 4. 
 
13C MRS data analysis  
A non-linear least-squares quantification algorithm, AMARES, as implemented in the 
jMRUI software package(52), was used to fit the 13C MRS data. The spectra were corrected for 
phase and DC offset. Soft constraints were imposed to peak frequencies (171.0–171.2 ppm 
for pyruvate, 161.0-161.4 ppm for bicarbonate and 183.2–183.6 ppm for lactate) and line 
widths (FWHM = 10–30 Hz) and the relative phases were fixed to zero. The peak areas of [1-
13C]lactate, [1-13C]pyruvate and [13C]bicarbonate were quantified, averaged over 25 
acquisitions (sum of the 2nd to 26th spectra, corresponding to a total acquisition time of 75 s), 
and used to compute the pyruvate-to-lactate and bicarbonate-to-lactate ratios. Changes in 
relative metabolite ratios were used as a measure of kinetic rate changes, because it was 
demonstrated before that that the kinetic rates obtained from fitting the evolution of the signals 
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of hyperpolarized substrates and its metabolic products are directly proportional to the ratios of 
the summed spectral signals(53). The time range was chosen such as to include only the 
spectra with a lactate signal-to-noise ratio (SNR) larger than 2.   
 
Statistics  
Statistical analyses were performed using the OriginPro 9.0G software. P values were 
computed using unpaired or paired Student’s t test, where appropriate. For the statistical 
analysis of multiple groups, one-way ANOVA was used followed by Tukey’s test. A p-value of 
0.05 was considered significant. All data are presented as mean ± standard error of the mean 
(SEM) unless otherwise stated. 
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Legends to Figures 
 
Figure 1. Representative dynamic 13C MRS spectra measured in a C57BL/6 mouse (left) and 
a NMRI mouse (right) head following the injection of hyperpolarized [1-13C]lactate. Along with 
the substrate resonance at 183 ppm, the three expected metabolites were detected: [1-
13C]pyruvate at 171 ppm, [13C]bicarbonate at 161 ppm, and [1-13C]alanine at 176 ppm 
(overlapping with an impurity peak). The delay between each acquisition was set to 3 s, 
starting 2 s after the beginning of the injection. A sum of the 2nd to 26th spectra is shown on top. 
 
Figure 2. (A) Pyruvate-to-lactate ratio deduced from the hyperpolarized 13C MRS experiments 
(sum of the 2nd to 26th spectra) performed in two different mice strains (C57BL/6 and NMRI). 
The ratio is significantly different for the two groups (p < 0.05). (B) Bicarbonate-to-lactate ratio 
deduced from the same experiments and for the two groups. The difference was not significant. 
Error bars represent the mean ± S.E.M. 
 
Figure 3. QPCR data for C57BL/6 (n=7) and NMRI mice (n=7). Only the Ldha expression level 
was significantly different between C57BL/6 and NMRI mice brain (p = 0.025). 
 
Figure 4. Schematic representation of 13C label distribution, across the detected metabolites in 
the mouse brain exposed to ultrasound (US; bottom), and not exposed to US (top), 75 s after 
the intravenous injection of [1-13C]lactate. Each square represents a metabolic pool, with the 
grey part corresponding to the of 13C labelled fraction. The grey arrows represent the 13C-label 
flux between the pools. Note that the relative size of the squares or the grey area within each 
pool are not scaled to the real pool size ratios or proportion of 13C label. 
 
Figure 5. (A) Pyruvate-to-lactate ratio deduced from the hyperpolarized 13C MRS experiments 
(sum of the 2nd to 26th spectra) performed in NMRI mice with or without ultrasound irradiation. 
The ratio is significantly different for the two groups (p < 0.05). (B) Bicarbonate-to-lactate ratio 
deduced from the same experiments and for the two groups. The differences were not 
significant. Error bars represent the mean ± S.E.M. 
